This page includes the latest FDA filings for Human Genome Sciences Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Human Genome Sciences, Inc. | Prescription Medication | 2024-06-20 |
Human Genome Sciences, Inc. | Prescription Medication | 2024-02-16 |
Human Genome Sciences, Inc. | Prescription Medication | 2023-02-21 |
Human Genome Sciences, Inc. | Prescription Medication | 2022-07-28 |
Human Genome Sciences, Inc. | Prescription Medication | 2022-02-18 |
Human Genome Sciences, Inc. | Prescription Medication | 2021-03-16 |
Human Genome Sciences, Inc. | Prescription Medication | 2020-12-19 |
Human Genome Sciences, Inc. | Prescription Medication | 2020-10-02 |
Human Genome Sciences, Inc. | Prescription Medication | 2020-06-07 |
Human Genome Sciences, Inc. | Prescription Medication | 2020-06-03 |
Human Genome Sciences, Inc. | Prescription Medication | 2020-01-25 |
Human Genome Sciences, Inc. | Prescription Medication | 2019-09-17 |
Human Genome Sciences, Inc. | Prescription Medication | 2019-04-30 |
Human Genome Sciences, Inc. | 2019-01-01 | |
Human Genome Sciences, Inc. | Prescription Medication | 2018-08-14 |
Human Genome Sciences, Inc. | 2018-04-09 | |
Human Genome Sciences, Inc. | BENLYSTA | 2017-07-20 |
Human Genome Sciences, Inc. | Raxibacumab | 2012-12-14 |
Human Genome Sciences, Inc. | BENLYSTA | 2011-03-10 |
Human Genome Sciences, Inc. | BENLYSTA | 2011-03-10 |
HUMAN GENOME SCIENCES INC. | 0000-00-00 00:00:00 | |
HUMAN GENOME SCIENCES INC. | 0000-00-00 00:00:00 |
NCAGE Code | 31SH4 | HUMAN GENOME SCIENCES, INC. |
CAGE Code | 31SH4 | HUMAN GENOME SCIENCES, INC. |
SEC | 0000901219 | HUMAN GENOME SCIENCES INC of DELAWARE |